stockrowBridgeBio Pharma, Inc.
BBIO Healthcare Biotechnology
BridgeBio Pharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.1 million, up 126.3% from fiscal 2024.
- Revenue
- +192.6%
- EPS
- +55.8%
- Free cash flow
- +60.5%
- Total debt
- +4.21%
Quarter to September 2026, against a year earlier
Follow BBIO
Alert me
BridgeBio Pharma, Inc. (BBIO) Operating margin
BridgeBio Pharma, Inc.'s operating margin over the twelve months to 30 September 2026 was −38.5%, up 65.7 percentage points from fiscal 2025 (−104.3%). Over the past ten years it has ranged from −6,528.8% (fiscal 2023) to 0.00% (fiscal 2018); the current reading is higher than 78% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −104.3% | 162.97 |
| FY2024 | −267.2% | 6,261.54 |
| FY2023 | −6,528.8% | (5,869.11) |
| FY2022 | −659.7% | 167.47 |
| FY2021 | −827.1% | 4,924.87 |
| FY2020 | −5,752.0% | (5,095.58) |
| FY2019 | −656.4% | (656.41) |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −3.30% | 40.64 |
| Jun 2026 | −43.9% | 10.53 |
| Mar 2026 | −54.5% | 36.05 |
| Dec 2025 | −90.5% | 29.78 |
| 28 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| EXEL Exelixis, Inc. compare | 40.2% |
| HALO Halozyme Therapeutics, Inc. compare | 37.4% |
| ASND Ascendis Pharma A/S compare | 24.8% |
| TECH Bio-Techne Corp compare | 20.7% |
| JAZZ Jazz Pharmaceuticals PLC compare | 9.03% |
| BMRN BioMarin Pharmaceutical Inc. compare | 3.12% |
| SMMT Summit Therapeutics PLC compare | 0.00% |
| KYMR Kymera Therapeutics, Inc. compare | 0.00% |
| BBIO BridgeBio Pharma, Inc. | −38.5% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on BBIO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement